APA

Zhou M., Hu Z., Qiu L., Zhou T., Feng M., Hu Q., Zeng B., Li Z., Sun Q., Wu Y., Liu X., Wu L. & Liang D. (20191010). Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells. : Human gene therapy.

Chicago

Zhou Miaojin, Hu Zhiqing, Qiu Liyan, Zhou Tao, Feng Mai, Hu Qian, Zeng Baitao, Li Zhuo, Sun Qianru, Wu Yong, Liu Xionghao, Wu Lingqian and Liang Desheng. 20191010. Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells. : Human gene therapy.

Harvard

Zhou M., Hu Z., Qiu L., Zhou T., Feng M., Hu Q., Zeng B., Li Z., Sun Q., Wu Y., Liu X., Wu L. and Liang D. (20191010). Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells. : Human gene therapy.

MLA

Zhou Miaojin, Hu Zhiqing, Qiu Liyan, Zhou Tao, Feng Mai, Hu Qian, Zeng Baitao, Li Zhuo, Sun Qianru, Wu Yong, Liu Xionghao, Wu Lingqian and Liang Desheng. Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells. : Human gene therapy. 20191010.